January 2018

FarmaMondo celebrates the recent successful establishment of its subsidiary in Copenhagen covering all 5 Nordic countries representing more than 27 million people. The Nordic expansion comes as a follow up to previous successful expansion to LATAM, Asia and CIS regions. FarmaMondo continues to invest...

Read the full interview, appeared on the magazine Healthcare and Life Sciences Review with our CEO, Mr. Jaron Spigel, regarding the uniqueness of FarmaMondo business model. With two billion people globally – predominantly in low and middle-income countries – having little or no access to medicine, a select group...

FarmaMondo SA announces it has established operations through its Global Access business unit into several south EU markets to allow direct to hospital supply of unlicensed medicines. The South European markets (Portugal, Spain, Italy and Greece) present a unique business and regulatory environment in the context of unlicensed medicines...